US › Healthcare

Allurion Technologies, Inc. (ALUR)

US · Healthcare · Medical Devices

$1.19+2.59%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$2.9M

Revenue YoY

-47.2%

Net profit

$-6.1M

EPS

$-6.90

EPS estimate

$-5.10

Net margin

-206.8%

EPS came in at -6.90 against a street estimate of -5.10 — a miss of 35.3%.

Key statistics

Market cap

$1.2M

Forward P/E

1.0

P/B

0.00

Book value

$-77.94

EPS (TTM)

$-59.40

52-week high

$8.52

52-week low

$0.23

50-day MA

$3.57

200-day MA

$1.83

Beta

-0.19

Analyst view

Analysts rate Allurion Technologies, Inc. a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $82.50.

Shareholding

Insiders

5.18%

Institutions

7.90%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Allurion Technologies, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.